|
ZMAT2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.282600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.990400E-01 |
| Normal-vs-Stage2 |
2.837800E-01 |
| Normal-vs-Stage3 |
5.489900E-02 |
| Normal-vs-Stage4 |
2.749800E-01 |
| Stage1-vs-Stage2 |
5.086400E-02 |
| Stage1-vs-Stage3 |
1.115990E-03 |
| Stage1-vs-Stage4 |
3.153700E-02 |
| Stage2-vs-Stage3 |
6.496600E-01 |
| Stage2-vs-Stage4 |
9.592200E-01 |
| Stage3-vs-Stage4 |
5.760200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.321200E-01 |
| Normal-vs-AfricanAmerican |
4.485800E-02 |
| Normal-vs-Asian |
8.452400E-01 |
| Caucasian-vs-AfricanAmerican |
6.011800E-02 |
| Caucasian-vs-Asian |
8.346200E-01 |
| AfricanAmerican-vs-Asian |
3.114000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.750800E-01 |
| Normal-vs-Female |
8.229200E-01 |
| Male-vs-Female |
7.063800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.251400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.298000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.195800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.422000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.075800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.886000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.415200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.433800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.747400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.786200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.447200E-01 |
| Normal-vs-Grade 2 |
8.505000E-01 |
| Normal-vs-Grade 3 |
6.299000E-01 |
| Normal-vs-Grade 4 |
1.298810E-01 |
| Grade 1-vs-Grade 2 |
6.253200E-01 |
| Grade 1-vs-Grade 3 |
5.344200E-01 |
| Grade 1-vs-Grade 4 |
2.336800E-01 |
| Grade 2-vs-Grade 3 |
4.243600E-01 |
| Grade 2-vs-Grade 4 |
6.622100E-02 |
| Grade 3-vs-Grade 4 |
2.563000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.192380E-02 |
| Normal-vs-ccB subtype |
6.601000E-03 |
| ccA subtype-vs-ccB subtype |
2.78050005242392E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.722200E-01 |
| Normal-vs-N1 |
8.787600E-02 |
| N0-vs-N1 |
2.291600E-01 |
|
|
